Dermatitis News and Research

Latest Dermatitis News and Research

Penn State investigator receives $7.3 million grant for research on cellular protein

A faculty member in Penn State's College of Agricultural Sciences has received a $7.3 million grant for innovative research on a cellular protein that could be a target for enhancing immune function in response to a variety of diseases and environmental toxins.

15 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

Protein that protects fetus during pregnancy could help treat atopic dermatitis

A protein which protects the fetus during pregnancy, HLA-G1, shows high potential for treating atopic dermatitis and other related diseases.

4 Aug 2017

Atopic dermatitis can affect adults more profoundly than younger patients

Eczema is not just kids' stuff. Although the skin disease is commonly diagnosed in infancy and early childhood, it also can affect adults - sometimes more profoundly than younger patients.

27 Jul 2017

Antiperspirants can be safely used during breast radiotherapy, study suggests

Women undergoing daily radiation therapy for breast cancer are commonly told they should not use antiperspirant for fear that it could cause greater radiation damage to the skin, but a new study from the Perelman School of Medicine at the University of Pennsylvania shows that advice is not based on sound science.

24 Jul 2017

Researchers discover mutations in CARD11 gene that lead to eczema

Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease.

19 Jun 2017

Cancer treatment may be effective therapy for psoriasis

HDAC inhibitors, already widely used to treat cancer, may be an effective therapy for psoriasis as well, scientists report.

31 May 2017

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.

12 May 2017

Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers

Cannabinoids contain anti-inflammatory properties that could make them useful in the treatment of a wide-range of skin diseases, according to researchers at the University of Colorado Anschutz Medical Campus.

18 Apr 2017

Scientists identify gene responsible for generating key lipid in skin barrier formation

Scientists have identified the gene responsible for generating acylceramide, the key lipid in forming the skin barrier that protects us from pathogens, allergens and other harmful substances. This finding could prove crucial in developing medicines for treating atopic dermatitis and ichthyosis.

17 Apr 2017

Silk garments unlikely to provide benefit for children with eczema

Wearing silk clothing offers no additional benefit for children who suffer from moderate to severe eczema, a study led by researchers at The University of Nottingham has found.

12 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

New treatment option could provide effective therapy for patients with dermatologic conditions

Alopecia areata, atopic dermatitis and vitiligo are highly visible dermatologic conditions that can have a negative effect on patients' quality of life and overall health. An emerging treatment option, however, could provide effective therapy for patients with these conditions.

3 Mar 2017

UC San Diego researchers suggest transplanting good bacteria to treat patients with atopic dermatitis

Healthy human skin is alive with bacteria. In fact, there are more microorganisms living in and on the human body than there are human cells. Most can live on the human skin without harming the host, but in some people bacteria can negatively alter their health, maybe even become life-threatening.

23 Feb 2017

New review examines use of probiotics or prebiotics for prevention of atopic dermatitis

Evidence supporting a key role for an altered gut microbiome in the development of atopic dermatitis would suggest that the use of probiotics or prebiotics to correct microbial imbalances in the gut could help prevent or treat AD.

31 Jan 2017

Contact dermatitis or contact eczema?

There is allergic contact dermatitis, which is mediated through an immune mechanism, this means that the person is specifically allergic to what they have come in to contact with their skin. Their body has had to go through a process whereby they have...

21 Dec 2016

FDA approves new treatment option for patients dealing with mild to moderate eczema

The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.

14 Dec 2016

New mathematical model suggests how AD may progress to become chronic

Successive flare-ups of the most common form of eczema may trigger an immune system overreaction, causing it to become a long-term condition in people.

8 Dec 2016

Study reveals why air pollutants cause some people to be at risk for atopic dermatitis

Tohoku University Graduate School of Medicine and Tohoku Medical Megabank Organization are pleased to announce the published results of a study into why air pollutants cause some people to be more susceptible to atopic dermatitis, a kind of skin inflammation.

29 Nov 2016

Common bacteria on human skin may offer protection against diseases

There are more and more examples of the ways in which we can benefit from our bacteria. According to researcher Rolf Lood from Lund University in Sweden, this is true for the skin as well.

11 Nov 2016

Dermatitis News and Research

Latest Dermatitis News and Research

Penn State investigator receives $7.3 million grant for research on cellular protein

FDA grants approval for new biosimilar to treat multiple types of cancer

Protein that protects fetus during pregnancy could help treat atopic dermatitis

Atopic dermatitis can affect adults more profoundly than younger patients

Antiperspirants can be safely used during breast radiotherapy, study suggests

Researchers discover mutations in CARD11 gene that lead to eczema

Cancer treatment may be effective therapy for psoriasis

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

Pharmaceuticals containing cannabinoids may be effective against skin diseases, say researchers

Scientists identify gene responsible for generating key lipid in skin barrier formation

Silk garments unlikely to provide benefit for children with eczema

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

New treatment option could provide effective therapy for patients with dermatologic conditions

UC San Diego researchers suggest transplanting good bacteria to treat patients with atopic dermatitis

New review examines use of probiotics or prebiotics for prevention of atopic dermatitis

Contact dermatitis or contact eczema?

FDA approves new treatment option for patients dealing with mild to moderate eczema

New mathematical model suggests how AD may progress to become chronic

Study reveals why air pollutants cause some people to be at risk for atopic dermatitis

Common bacteria on human skin may offer protection against diseases

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dermatitis News and Research

Latest Dermatitis News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in